GlassScriptPhysician profile
Jan Garcia
NPI 1962478933
$1,644.29
in general payments reported to CMS, 2019-2025
10 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,007 · 2020: $33.19 · 2021: $310 · 2022: $31.42 · 2024: $25.48 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $498.17 | 2021-2025 | Matrixmandible, Matrixwave, Matrixmidface |
| Merz North America, INC. | $492.04 | 2019 | |
| Sientra, INC. | $158.64 | 2019-2021 | |
| Coopersurgical, INC. | $113.55 | 2019 | |
| Baxter Healthcare | $108.69 | 2019 | |
| Tepha INC | $92.93 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $76.08 | 2019-2021 | |
| Medline Industries LP | $66.07 | 2019 | |
| Medtronic Vascular, INC. | $20.29 | 2019 | |
| Apyx Medical Corporation | $17.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.